6883

SHH:688399

Jiangsu Bioperfectus Technologies Co., Ltd.

Add to Watchlist
  • Stock

64.67

−0.06%

−0.04

CNY last updated 20/08 01:43:28

Last Close

64.71

30/04 07:00

Market Cap

4.01B

Beta: 1.04

Volume Today

285.28K

Avg: 492.31K

PE Ratio

113.16

PFCF: −706.40

The Aequitas Research team provided a weekly update on IPOs, lock-up expirations, and other ECM-related events that took place in the past week. The report covers insights on Jiangsu Hengrui Pharmaceutical's A/H shares premium analysis, Jiangsu Zenergy Battery Technologies' IPO insights, and Chaoge Holdings' IPO start and valuation. The report also includes market analysis from India and other regions.

smartkarma.com

    Description

    Jiangsu Bioperfectus Technologies Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting detectors, as well as in vitro testing services. The company was founded in 2010 and is based in Taizhou, China.

    Earnings

    Earnings per Share (Estimate*)

    -22468102020-03-302020-12-312022-06-292022-12-312024-03-30

    Revenue (Estimate*)

    500M1B1.50B2020-03-302020-12-312022-06-292022-12-312024-03-30

    *Estimate based on analyst consensus